Showing results (261-270 of 346) with videos related to

Sort By:
Pageof 35
Biochemistry|March 2, 2005
Interaction of phosphonate analogues of the tetrahedral reaction intermediate with 5-enolpyruvylshikimate-3-phosphate synthase in atomic detailMelanie A Priestman, Martha L Healy, Andreas Becker, et al.
Clinical Orthopaedics and Related Research|January 1, 1993
Methylmethacrylate monomer and fat content in shed blood after total joint arthroplastyW L Healy, S A Wasilewski, B A Pfeifer, et al.
Gynecologic Oncology|November 1, 1994
A prospective study of inhibin in granulosa cell tumors of the ovaryT Jobling, P Mamers, D L Healy, et al.
The Journal of Clinical Endocrinology and Metabolism|December 1, 1988
Occult ovarian failure: a syndrome of infertility, regular menses, and elevated follicle-stimulating hormone concentrationsI T Cameron, F C O'Shea, J M Rolland, et al.
Human Reproduction (Oxford, England)|April 30, 2008
Factors affecting low birthweight after assisted reproduction technology: difference between transfer of fresh and cryopreserved embryos suggests an adverse effect of oocyte collectionW Shih, D D Rushford, H Bourne, et al.
Circulation. Cardiovascular Imaging|October 5, 2023
Atrial Myopathy Quantified by Speckle-tracking Echocardiography in MiceMichael J Zhang, Dylan J Gyberg, Chastity L Healy, et al.
Psychological Services|February 5, 2019
Trauma-informed care in practice: Observed use of psychosocial care practices with children and families in a large pediatric hospitalKatrina M Moss, Karyn L Healy, Jenny Ziviani, et al.
The Journal of Clinical Endocrinology and Metabolism|November 3, 2005
Effects of high-dose growth hormone on glucose and glycerol metabolism at rest and during exercise in endurance-trained athletesM L Healy, J Gibney, C Pentecost, et al.
Reproduction, Fertility, and Development|January 1, 1991
Concentrations of immunoactive inhibin in serum during human pregnancy: evidence for an ovarian contributionT Yohkaichiya, D Polson, A O'Connor, et al.
Reproduction, Fertility, and Development|January 1, 1990
Second-trimester termination with 16,16 dimethyl-PGE1-methyl ester (gemeprost), compared with a regimen that included intra-amniotic PGF2 alpha and hypertonic salineK W Waldron, P M Renou, N Lolatgis, et al.
Pageof 35